272 related articles for article (PubMed ID: 10907640)
1. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes.
Boudard D; Sordet O; Vasselon C; Revol V; Berthéas MF; Freyssenet D; Viallet A; Piselli S; Guyotat D; Campos L
Leukemia; 2000 Dec; 14(12):2045-51. PubMed ID: 11187891
[TBL] [Abstract][Full Text] [Related]
3. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
4. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes.
Ali A; Mundle SD; Ragasa D; Reza S; Shetty V; Mativi BY; Cartlidge JD; Azharuddin M; Qawi H; Dar S; Raza A
J Hematother Stem Cell Res; 1999 Aug; 8(4):343-56. PubMed ID: 10634172
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
6. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells.
Andersson M; Sjöstrand J; Petersen A; Honarvar AK; Karlsson JO
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2623-32. PubMed ID: 10937575
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of caspases activity of hematopoietic progenitor cells and its significance in myelodysplastic syndromes].
Chen JL; Xu M; Song XZ; Li Q; Li RS
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):565-7. PubMed ID: 14720439
[TBL] [Abstract][Full Text] [Related]
8. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis.
Yang B; El Nahas AM; Fisher M; Wagner B; Huang L; Storie I; Barnett D; Barratt J; Smith AC; Johnson TS
Nephron Exp Nephrol; 2004; 96(2):e39-51. PubMed ID: 14988591
[TBL] [Abstract][Full Text] [Related]
10. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A
Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080
[TBL] [Abstract][Full Text] [Related]
12. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
Irvine AE; Magill MK; Somerville LE; McMullin MF
Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia.
Witherspoon RP; Deeg HJ
Haematologica; 1999 Dec; 84(12):1085-7. PubMed ID: 10586209
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
[TBL] [Abstract][Full Text] [Related]
17. Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes.
Mundle SD; Reza S; Ali A; Mativi Y; Shetty V; Venugopal P; Gregory SA; Raza A
Cancer Lett; 1999 Jun; 140(1-2):201-7. PubMed ID: 10403560
[TBL] [Abstract][Full Text] [Related]
18. Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect.
Sáez-Valero J; Angeretti N; Forloni G
Neurosci Lett; 2000 Nov; 293(3):207-10. PubMed ID: 11036197
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
Merchant SH; Gonchoroff NJ; Hutchison RE
Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of apoptosis by caspase inhibitor Z-VAD-FMK improves cryotolerance of in vitro derived bovine embryos.
Pero ME; Zullo G; Esposito L; Iannuzzi A; Lombardi P; De Canditiis C; Neglia G; Gasparrini B
Theriogenology; 2018 Mar; 108():127-135. PubMed ID: 29207293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
